Spain Reimbursement Profile
By Jesús Cuervo, PhD, Carlos Crespo, MBA, MHE, PhD, Jenifer Ehreth, MHA, PhD -
Published 27 September 2017
This profile summarizes the reimbursement process in Spain, presents key stakeholders and highlights what should be considered early in the development process.
Categories: Features, Europe, Biologics and biotechnology, Drugs, Medical Devices, Reimbursement
Tags: Spain, AEMPS, Agencia Española de Medicamentos y Productos Sanitarios
Spanish Regulator Cites Madrid Drugmaker for Manufacturing Violations
By Michael Mezher -
Published 20 December 2016
The Spanish Agency of Medicines and Medical Devices (AEMPS) has issued a statement of non-compliance to Madrid, Spain-based drugmaker Angulema, S.L., and ordered the recall of more than 400 lots of the company's vaccines.
Categories: News, Europe, Biologics and biotechnology, Manufacturing, Quality
Tags: AEMPS, Angulema
Spain Launches new Registry of API Manufacturers, Distributors, Importers
By Louise Zornoza, RegLink -
Published 18 July 2014
The Spanish Agency for Medicines and Health Products (AEMPS) has launched a registry of businesses involved in the manufacture, import and distribution of pharmaceutical active ingredients in Spain.
Categories: News, Europe, Active pharmaceutical ingredients, Submission and registration
Tags: Spain, API, Active Pharmaceutical Ingredient, AEMPS, Registration
Italian, Swiss, Spanish Regulators Ban Sale of Novartis Flu Vaccines
By Alexander Gaffney, RF News Editor -
Published 26 October 2012
Tags: AEMPS, SwissMedic, AIFA, Flaud, Agrippal, Vaccine, Influenza, Flu, Novartis, Latest News